Women with epilepsy (WWE) wishing for a child represent a highly relevant subgroup of
epilepsy patients. The treating epileptologist needs to delineate the epilepsy syndrome and …

As prenatal exposure to certain older antiseizure medications (ASMs) has been linked with
poorer neurodevelopmental outcomes in children, the use of newer ASMs throughout …

Background Valproate is a first-line treatment for patients with newly diagnosed idiopathic
generalised or difficult to classify epilepsy, but not for women of child-bearing potential …

Importance Valproate is used for the treatment of epilepsy and other neuropsychological
disorders and may be the only treatment option for women of childbearing potential …

Importance The neurodevelopmental risks of fetal exposure are uncertain for many
antiseizure medications (ASMs). Objective To compare children at 2 years of age who were …

When used during pregnancy, benzodiazepines (BZDs) and related z-drugs could pass
readily through the placenta and the foetal blood-brain barrier, where they can bind to γ …

Importance The association of fetal exposure to antiseizure medications (ASMs) with
outcomes in childhood are not well delineated. Objective To examine the association of fetal …

Epilepsy is a group of neurological diseases characterized by susceptibility to recurrent
seizures. Antiseizure medications (ASMs) are the mainstay of treatment, but many …

The aims of the SANAD II trial were to assess the longer-term clinical effectiveness and
costeffectiveness of levetiracetam and zonisamide compared with lamotrigine in focal …

Persons with epilepsy (PWE) have a high risk of premature death with a two to fourfold
increased standardized mortality ratios (SMR) compared with the background population. 1 …